HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty’s Consumer Biz Leads Q1 As Supply Issues, China Lockdowns Offset Prestige Beauty Demand

Executive Summary

Fragrance component shortages and COVID-19 restrictions in China were among factors that dragged on Coty’s Prestige business growth in the first quarter of fiscal 2023. Nevertheless, the division’s sales rose 7% like-for-like, while Consumer Beauty grew 12% on the strength of restaged brands.

You may also be interested in...



Coty’s First Refillable Fragrance Among 2022 Sustainability Highlights

Chloé Rose Naturelle Intense, Coty’s first refillable fragrance, makes its 2022 sustainability report along with green science to replace D5 silicone and the company’s partnership with LanzaTech NZ to create fragrances using ethanol made from captured carbon emissions.

Coty’s China Momentum Reflects Consumer ‘Obsession’ With Prestige; Q3 Sales Up 15%

Expecting China to evolve into the largest prestige beauty market in the world, Coty believes it is well-positioned to benefit as one of the fastest-growing beauty firms in the country as consumers increasingly flock to fragrance. The firm’s Asia Pacific sales grew 9% in the fiscal third quarter, reported, to $158.1m.

Coty Extends Winning CoverGirl ‘Clean’ Strategy To Rimmel Makeup, Debuting Now

Rimmel Kind & Free follows CoverGirl Clean rollouts last year, which have helped to rejuvenate the iconic brand and endear it to a younger audience. Coty’s Consumer Beauty division recorded an 11% increase in FY 2022 second-quarter sales to $570.2m, reported, capturing global market share for the first time in five years.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel